doc. MUDr. Daniela Žáčková, Ph.D.

2026

• Development of a prognostic scoring system for chronic myeloid leukemia in blast phase

  LAUSEKER Michael SACHA Tomasz KLAMOVA Hana YAKOLEVA Julia LOMAIA Elza MILOJKOVIC Dragana FABISCH Christian NICOLINI Franck E OLSSON-STROMBERG Ulla ŽÁČKOVÁ Daniela LEWANDOWSKI Krzysztof ERNST Philipp CASTAGNETTI Fausto HIRSCHBUHL Klaus ZUPAN Irena VOSKANYAN Astghik GOLOS Aleksandra FRIETSCH Jochen J GIL Justyna FABER Edgar KRAUSE Stefan W PARRY Anne SAUSSELE Susanne HEIBL Sonja FRANKE Georg-Nikolaus CASADO Luis Felipe PACZKOWSKA Edyta HEBART Holger EDER Matthias ANHUT Peter TRAUTMANN-GRILL Karolin SZCZEPANEK Elzbieta SUDHOFF Thomas PATKOWSKA Elzbieta KIANI Alexander ERNST Thomas APPERLEY Jane MAYER Jiri HOCHHAUS Andreas PFIRRMANN Markus BRIOLI Annamaria

  Peer-reviewed scientific article

  Leukemia, year: 2026, DOI

• The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

  PERUSINI Maria Agustina PAGNANO Katia PAVLOVSKY Carolina ŽÁČKOVÁ Daniela MAYER Jiří MOIRAGHI Beatriz VARELA Ana Ines BIANCHINI Michele BEATRIZ Pascoal Lopes Ana DUARTE Gislaine ANTONIO De Souza Carmino JEŽÍŠKOVÁ Ivana HRONSKÁ Anežka JURČEK Tomáš HYE Won Lee CHANG Myung Hee MEDEIROS Jessie J F ABELSON Sagi KIM Dennis Dong Hwan

  Peer-reviewed scientific article

  Leukemia, year: 2026, DOI

2025

• Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia

  MAYER Jiří ČIČÁTKOVÁ Petra KOVACOVA Lenka JAROŠOVÁ Marie KARAS Michal JINDRA Pavel KLAMOVA Hana MACHOVA POLAKOVA Katerina CERNA Olga CMUNT Eduard BELOHLAVKOVA Petra ZAK Pavel FABER Edgar PAPAJIK Tomas STEJSKAL Lukas JEŽÍŠKOVÁ Ivana WEINBERGEROVÁ Barbora JURČEK Tomáš HORŇÁK Tomáš ŽÁČKOVÁ Daniela RANSDORFOVA Sarka HOLZEROVA Milena PAVLÍK Tomáš

  Peer-reviewed scientific article

  American Journal of Hematology, year: 2025, volume: 100, edition: 4, DOI

• Potential differences between real-life and randomized controlled trial populations in chronic myeloid leukemia

  HORŇÁK Tomáš ŽÁČKOVÁ Daniela MAYER Jiří

  Peer-reviewed scientific article

  Annals of hematology, year: 2025, volume: 104, edition: 11, DOI

• Total psoriasis regression in a patient with chronic myeloid leukemia treated using nilotinib

  HORŇÁK Tomáš ŽÁČKOVÁ Daniela MAYER Jiří

  Peer-reviewed scientific article

  Annals of Hematology, year: 2025, volume: 104, edition: 3, DOI

2024

• AKCELEROVANÁ FÁZE BY MĚLA BÝT SOUČÁSTÍ KLASIFIKACE CHRONICKÉ MYELOIDNÍ LEUKEMIE I V ÉŘE EXISTENCE INHIBITORŮ TYROZINKINÁZ

  HORŇÁK Tomáš MAYER Jiří ČIČÁTKOVÁ Petra SEMERÁD Lukáš KVETKOVÁ Anežka KLAMOVÁ H. FABER F. BĚLOHLÁVKOVÁ Petra KARAS M. STEJSKAL L. CMUNT E. ČERNÁ O. SRBOVÁ D. ŽIŽKOVÁ H. VRÁBLOVÁ L. SKOUMALOVÁ I. VOGLOVÁ J. JURKOVÁ T. CHRÁPAVÁ M. JURČEK Tomáš JEŽÍŠKOVÁ Ivana JAROŠOVÁ Marie MACHOVÁ POLÁKOVÁ Kateřina PAPAJÍK Tomáš ŽÁK P. JINDRA P. ŽÁČKOVÁ Daniela

  Conference abstract

  Year: 2024, type: Conference abstract

• Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data

  BELOHLAVKOVA Petra ŽÁČKOVÁ Daniela KLAMOVA Hana FABER Edgar KARAS Michal STEJSKAL Lukas CMUNT Eduard CERNA Olga JEŽÍŠKOVÁ Ivana MACHOVA POLAKOVA Katerina ZAK Pavel JURKOVÁ Tereza CHRÁPAVÁ Marika MAYER Jiří

  Peer-reviewed scientific article

  Cancer Medicine, year: 2024, volume: 13, edition: 17, DOI

• Cytogenomická a molekulárně biologická analýzanádorového genomu pacientů s myeloidními malignitami se zaměřením na akutní myeloidní leukémii s komplexními změnami a na analýzu genu MECOM

  BRYJOVÁ Lenka ČÁBELOVÁ Kateřina ONDROUŠKOVÁ Eva BOHÚNOVÁ M. ŠMUHAŘOVÁ Petra ŠMEJKAL Jiří KOTAŠKOVÁ Jana JEŽÍŠKOVÁ Ivana FOLTA Adam SMITALOVÁ Dagmar DOUBEK Michael WEINBERGEROVÁ Barbora ČERVINEK Libor PANOVSKÁ Anna ŽÁČKOVÁ Daniela POSPÍŠILOVÁ Šárka JAROŠOVÁ Marie

  Conference abstract

  Year: 2024, type: Conference abstract

• De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors

  HORŇÁK Tomáš MAYER Jiří ČIČÁTKOVÁ Petra SEMERÁD Lukáš KVETKOVÁ Anežka KLAMOVA Hana FABER Edgar BELOHLAVKOVA Petra KARAS Michal STEJSKAL Lukas CMUNT Eduard CERNA Olga SRBOVA Dana ZIZKOVA Hana VRABLOVA Lucia SKOUMALOVA Ivana VOGLOVA Jaroslava JURKOVA Tereza CHRAPAVA Marika JURČEK Tomáš JEŽÍŠKOVÁ Ivana JAROŠOVÁ Marie MACHOVA POLAKOVA Katerina PAPAJIK Tomas ZAK Pavel JINDRA Pavel ŽÁČKOVÁ Daniela

  Peer-reviewed scientific article

  American Journal of Hematology, year: 2024, volume: 99, edition: 4, DOI

• Expression of the immune checkpoint inhibitors on gamma-delta T cells in chronic myeloid leukemia patients during TKI therapy

  KNIGHT Andrea PISKÁČEK Martin TOMANDLOVÁ Marie SLAMEČKOVÁ Tereza PROCHÁZKOVÁ Jiřina ŽÁČKOVÁ Daniela MAYER Jiří

  Appeared in Conference without Proceedings

  Year: 2024, type: Appeared in Conference without Proceedings